MedPath
HSA Approval

VIEPAX XR TABLET 150MG

SIN15968P

VIEPAX XR TABLET 150MG

VIEPAX XR TABLET 150MG

June 29, 2020

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, EXTENDED RELEASE

ORAL

Medical Information

N06AX16

venlafaxine

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

DEXCEL PHARMA TECHNOLOGIES LTD.

Active Ingredients

Venlafaxine Hydrochloride eqv to Venlafaxine

150mg

Venlafaxine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VIEPAX XR TABLET 150MG - HSA Approval | MedPath